Kiromic BioPharma
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Kiromic BioPharma's balance sheet done over the years? Its assets were worth $12,169,000 last year, which is more than in the previous period. 175% of Kiromic BioPharma’s total assets is currently financed by debt. Its liabilities reached the amount of $21,289,800, which means an increase by 20% compared compared to last year.

Debt to Assets

Kiromic BioPharma, Inc. (NASDAQ:KRBP): Debt to assets
2018 876000 610.7K 69.71%
2019 2652700 673.7K 25.4%
2020 12829700 1.46M 11.44%
2021 30729600 3.40M 11.1%
2022 11967500 17.74M 148.25%
2023 12169000 21.28M 174.95%

KRBP Balance Sheet (2018 – 2023)

2023 2022 2021 2020 2019 2018
Assets
Current assets:
Cash and cash equivalents
3.20M645.2K25.35M10.15M1.92M384.3K
Short term investments
000000
Net receivables
0016.2K0024.3K
Inventory
000022.2K16.3K
Other current assets
1.22M1.04M1.69M588.8K89.1K135.3K
Total current assets
4.43M1.68M27.06M10.73M2.04M560.2K
Non-current assets:
Property, Plant and Equipment
7.71M10.25M3.62M2.06M587.9K298K
Goodwill
000000
Intangible assets
000000
Long term investments
000000
Other non-current assets
21.4K24.4K31.1K24.4K24.4K17.8K
Total non-current assets
7.73M10.27M3.66M2.09M612.3K315.8K
Total assets
12.16M11.96M30.72M12.82M2.65M876K
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
000000
Short term debt
14.63M4.95M454.5K468K00
Total current liabilities
20.37M13.28M3.40M1.46M673.7K610.7K
Non-current liabilities:
Long term debt
911.5K4.45M0000
Deferred tax
000000
Other non-current liabilities
000000
Total non-current liabilities
911.5K4.45M0000
Total liabilities
21.28M17.74M3.40M1.46M673.7K610.7K
Data sourceData sourceData sourceData source